Search research articles
Contact Us
Filters
Showing results (331-340 of 523) with videos related to
Page
of 53
Sort By:
Journal of the American Academy of Dermatology
|
January 19, 2016
Translating psoriasis guidelines into practice: Important gaps revealed
Reva Bhushan, Mark G Lebwohl, Alice B Gottlieb, et al.
The Journal of Rheumatology
|
April 2, 2022
Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting
Jenna E Yousif, Joseph F Merola, Lourdes M Perez-Chada, et al.
The Journal of Investigative Dermatology
|
October 1, 1994
GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo
S Braunstein, G Kaplan, A B Gottlieb, et al.
The Journal of Rheumatology
|
November 3, 2012
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting
April W Armstrong, Kristina Callis Duffin, Amit Garg, et al.
Clinical and Experimental Dermatology
|
May 11, 2024
Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry
Carly Grant, Lourdes M Perez-Chada, Ryan W Harrison, et al.
Boletin Chileno De Parasitologia
|
July 1, 1994
[Familial seroepidemiology of toxocariasis]
I Noemi, E Rugiero, A Viovy, et al.
The Journal of Experimental Medicine
|
December 1, 1995
Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells
J G Krueger, J T Wolfe, R T Nabeya, et al.
Plos One
|
April 12, 2012
Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis
Yumiko Wada, Irma Cardinale, Artemis Khatcherian, et al.
Dermatology and Therapy
|
March 13, 2022
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Boni E Elewski, Andrew Blauvelt, Gaia Gallo, et al.
Journal of the American Academy of Dermatology
|
June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study
Andrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
Page
of 53
Search research articles
Search
Showing results (331-340 of 523) with videos related to
Sort By:
Page
of 53
Journal of the American Academy of Dermatology
|
January 19, 2016
Translating psoriasis guidelines into practice: Important gaps revealed
Reva Bhushan, Mark G Lebwohl, Alice B Gottlieb, et al.
The Journal of Rheumatology
|
April 2, 2022
Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting
Jenna E Yousif, Joseph F Merola, Lourdes M Perez-Chada, et al.
The Journal of Investigative Dermatology
|
October 1, 1994
GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo
S Braunstein, G Kaplan, A B Gottlieb, et al.
The Journal of Rheumatology
|
November 3, 2012
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting
April W Armstrong, Kristina Callis Duffin, Amit Garg, et al.
Clinical and Experimental Dermatology
|
May 11, 2024
Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry
Carly Grant, Lourdes M Perez-Chada, Ryan W Harrison, et al.
Boletin Chileno De Parasitologia
|
July 1, 1994
[Familial seroepidemiology of toxocariasis]
I Noemi, E Rugiero, A Viovy, et al.
The Journal of Experimental Medicine
|
December 1, 1995
Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells
J G Krueger, J T Wolfe, R T Nabeya, et al.
Plos One
|
April 12, 2012
Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis
Yumiko Wada, Irma Cardinale, Artemis Khatcherian, et al.
Dermatology and Therapy
|
March 13, 2022
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Boni E Elewski, Andrew Blauvelt, Gaia Gallo, et al.
Journal of the American Academy of Dermatology
|
June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study
Andrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
Page
of 53